메뉴 건너뛰기




Volumn 2014, Issue , 2014, Pages

CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN B; CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN E; CYCLINE; FLAVOPIRIDOL; GENISTEIN; IBUPROFEN; INDIRUBIN; NONSTEROID ANTIINFLAMMATORY AGENT; PALBOCICLIB; SORAFENIB; TAMOXIFEN; TANSHINONE IIA; CYCLIN DEPENDENT KINASE INHIBITOR;

EID: 84896825938     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/361020     Document Type: Review
Times cited : (60)

References (143)
  • 1
    • 0029849620 scopus 로고    scopus 로고
    • Cancer cell cycles
    • 2-s2.0-0029849620 10.1126/science.274.5293.1672
    • Sherr C. J., Cancer cell cycles. Science 1996 274 5293 1672 1674 2-s2.0-0029849620 10.1126/science.274.5293.1672
    • (1996) Science , vol.274 , Issue.5293 , pp. 1672-1674
    • Sherr, C.J.1
  • 2
    • 0028568315 scopus 로고
    • Cell cycle control and cancer
    • 2-s2.0-0028568315
    • Hartwell L. H., Kastan M. B., Cell cycle control and cancer. Science 1994 266 5192 1821 1828 2-s2.0-0028568315
    • (1994) Science , vol.266 , Issue.5192 , pp. 1821-1828
    • Hartwell, L.H.1    Kastan, M.B.2
  • 4
    • 0027742184 scopus 로고
    • Distinct roles for cyclin-dependent kinases in cell cycle control
    • 2-s2.0-0027742184
    • van den Heuvel S., Harlow E., Distinct roles for cyclin-dependent kinases in cell cycle control. Science 1993 262 5142 2050 2054 2-s2.0-0027742184
    • (1993) Science , vol.262 , Issue.5142 , pp. 2050-2054
    • Van Den Heuvel, S.1    Harlow, E.2
  • 5
    • 0029033861 scopus 로고
    • The retinoblastoma protein and cell cycle control
    • 2-s2.0-0029033861
    • Weinberg R. A., The retinoblastoma protein and cell cycle control. Cell 1995 81 3 323 330 2-s2.0-0029033861
    • (1995) Cell , vol.81 , Issue.3 , pp. 323-330
    • Weinberg, R.A.1
  • 6
    • 0025033793 scopus 로고
    • Cell cycle control in eukaryotes molecular mechanisms of cdc2 activation
    • 2-s2.0-0025033793
    • Draetta G., Cell cycle control in eukaryotes molecular mechanisms of cdc2 activation. Trends in Biochemical Sciences 1990 15 10 378 383 2-s2.0-0025033793
    • (1990) Trends in Biochemical Sciences , vol.15 , Issue.10 , pp. 378-383
    • Draetta, G.1
  • 7
    • 0033564697 scopus 로고    scopus 로고
    • CDK inhibitors: Positive and negative regulators of G1-phase progression
    • 2-s2.0-0033564697
    • Sherr C. J., Roberts J. M., CDK inhibitors: positive and negative regulators of G1-phase progression. Genes and Development 1999 13 12 1501 1512 2-s2.0-0033564697
    • (1999) Genes and Development , vol.13 , Issue.12 , pp. 1501-1512
    • Sherr, C.J.1    Roberts, J.M.2
  • 9
    • 0028931265 scopus 로고
    • Principles of CDK regulation
    • 2-s2.0-0028931265
    • Morgan D. O., Principles of CDK regulation. Nature 1995 374 6518 131 134 2-s2.0-0028931265
    • (1995) Nature , vol.374 , Issue.6518 , pp. 131-134
    • Morgan, D.O.1
  • 10
    • 0027717617 scopus 로고
    • P21 is a universal inhibitor of cyclin kinases
    • 2-s2.0-0027717617 10.1038/366701a0
    • Xiong Y., Hannon G. J., Zhang H., Casso D., Kobayashi R., Beach D., p21 is a universal inhibitor of cyclin kinases. Nature 1993 366 6456 701 704 2-s2.0-0027717617 10.1038/366701a0
    • (1993) Nature , vol.366 , Issue.6456 , pp. 701-704
    • Xiong, Y.1    Hannon, G.J.2    Zhang, H.3    Casso, D.4    Kobayashi, R.5    Beach, D.6
  • 11
    • 0032146274 scopus 로고    scopus 로고
    • The regulation of E2F by pRB-family proteins
    • 2-s2.0-0032146274
    • Dyson N., The regulation of E2F by pRB-family proteins. Genes and Development 1998 12 15 2245 2262 2-s2.0-0032146274
    • (1998) Genes and Development , vol.12 , Issue.15 , pp. 2245-2262
    • Dyson, N.1
  • 13
    • 0028171292 scopus 로고
    • G1 phase progression: Cycling on cue
    • 2-s2.0-0028171292 10.1016/0092-8674(94)90540-1
    • Sherr C. J., G1 phase progression: cycling on cue. Cell 1994 79 4 551 555 2-s2.0-0028171292 10.1016/0092-8674(94)90540-1
    • (1994) Cell , vol.79 , Issue.4 , pp. 551-555
    • Sherr, C.J.1
  • 14
    • 0033629383 scopus 로고    scopus 로고
    • Cell cycle regulation by the Cdc25 phosphatase family
    • 2-s2.0-0033629383
    • Nilsson I., Hoffmann I., Cell cycle regulation by the Cdc25 phosphatase family. Progress in Cell Cycle Research 2000 4 107 114 2-s2.0-0033629383
    • (2000) Progress in Cell Cycle Research , vol.4 , pp. 107-114
    • Nilsson, I.1    Hoffmann, I.2
  • 15
    • 0024425887 scopus 로고
    • Checkpoints: Controls that ensure the order of cell cycle events
    • 2-s2.0-0024425887
    • Hartwell L. H., Weinert T. A., Checkpoints: controls that ensure the order of cell cycle events. Science 1989 246 4930 629 634 2-s2.0-0024425887
    • (1989) Science , vol.246 , Issue.4930 , pp. 629-634
    • Hartwell, L.H.1    Weinert, T.A.2
  • 16
    • 0034121281 scopus 로고    scopus 로고
    • Cell cycle molecular targets in novel anticancer drug discovery
    • 2-s2.0-0034121281
    • Buolamwini J. K., Cell cycle molecular targets in novel anticancer drug discovery. Current Pharmaceutical Design 2000 6 4 379 392 2-s2.0-0034121281
    • (2000) Current Pharmaceutical Design , vol.6 , Issue.4 , pp. 379-392
    • Buolamwini, J.K.1
  • 17
    • 0027938209 scopus 로고
    • Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
    • 2-s2.0-0027938209 10.1016/0092-8674(94)90543-6
    • Hunter T., Pines J., Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 1994 79 4 573 582 2-s2.0-0027938209 10.1016/0092-8674(94) 90543-6
    • (1994) Cell , vol.79 , Issue.4 , pp. 573-582
    • Hunter, T.1    Pines, J.2
  • 18
    • 0028915222 scopus 로고
    • Molecular foundations of cancer: New targets for intervention
    • 2-s2.0-0028915222
    • Karp J. E., Broder S., Molecular foundations of cancer: new targets for intervention. Nature Medicine 1995 1 4 309 320 2-s2.0-0028915222
    • (1995) Nature Medicine , vol.1 , Issue.4 , pp. 309-320
    • Karp, J.E.1    Broder, S.2
  • 19
    • 0028172572 scopus 로고
    • Mammalian G1 cyclins
    • 2-s2.0-0028172572 10.1016/0955-0674(94)90054-X
    • Draetta G. F., Mammalian G1 cyclins. Current Opinion in Cell Biology 1994 6 6 842 846 2-s2.0-0028172572 10.1016/0955-0674(94)90054-X
    • (1994) Current Opinion in Cell Biology , vol.6 , Issue.6 , pp. 842-846
    • Draetta, G.F.1
  • 21
    • 0029921317 scopus 로고    scopus 로고
    • Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
    • 2-s2.0-0029921317
    • Hall M., Peters G., Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Advances in Cancer Research 1996 68 67 108 2-s2.0-0029921317
    • (1996) Advances in Cancer Research , vol.68 , pp. 67-108
    • Hall, M.1    Peters, G.2
  • 25
    • 34447333658 scopus 로고    scopus 로고
    • Assessment of the proliferative status of epithelial cell types in the endometrium of young and menopausal transition women
    • 2-s2.0-34447333658 10.1093/humrep/dem032
    • Niklaus A. L., Aubuchon M., Zapantis G., Li P., Qian H., Isaac B., Kim M. Y., Adel G., Pollard J. W., Santoro N. F., Assessment of the proliferative status of epithelial cell types in the endometrium of young and menopausal transition women. Human Reproduction 2007 22 6 1778 1788 2-s2.0-34447333658 10.1093/humrep/dem032
    • (2007) Human Reproduction , vol.22 , Issue.6 , pp. 1778-1788
    • Niklaus, A.L.1    Aubuchon, M.2    Zapantis, G.3    Li, P.4    Qian, H.5    Isaac, B.6    Kim, M.Y.7    Adel, G.8    Pollard, J.W.9    Santoro, N.F.10
  • 26
    • 0031307157 scopus 로고    scopus 로고
    • The role of cyclin e in cell proliferation, development and cancer
    • 2-s2.0-0031307157
    • Keyomarsi K., Herliczek T. W., The role of cyclin E in cell proliferation, development and cancer. Progress in Cell Cycle Research 1997 3 171 191 2-s2.0-0031307157
    • (1997) Progress in Cell Cycle Research , vol.3 , pp. 171-191
    • Keyomarsi, K.1    Herliczek, T.W.2
  • 27
    • 0032931766 scopus 로고    scopus 로고
    • Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers
    • 2-s2.0-0032931766
    • Gudas J. M., Payton M., Thukral S., Chen E., Bass M., Robinson M. O., Coats S., Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers. Molecular and Cellular Biology 1999 19 1 612 622 2-s2.0-0032931766
    • (1999) Molecular and Cellular Biology , vol.19 , Issue.1 , pp. 612-622
    • Gudas, J.M.1    Payton, M.2    Thukral, S.3    Chen, E.4    Bass, M.5    Robinson, M.O.6    Coats, S.7
  • 29
    • 0026636121 scopus 로고
    • Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma
    • 2-s2.0-0026636121
    • Wang J., Zindy F., Chenivesse X., Lamas E., Henglein B., Brechot C., Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene 1992 7 8 1653 1656 2-s2.0-0026636121
    • (1992) Oncogene , vol.7 , Issue.8 , pp. 1653-1656
    • Wang, J.1    Zindy, F.2    Chenivesse, X.3    Lamas, E.4    Henglein, B.5    Brechot, C.6
  • 30
    • 0345369607 scopus 로고    scopus 로고
    • Amplified CDK2 and cdc2 activities in primary colorectal carcinoma
    • Kim J. H., Kang M. J., Park C. U., Amplified CDK2 and cdc2 activities in primary colorectal carcinoma. Cancer 1999 85 3 546 553
    • (1999) Cancer , vol.85 , Issue.3 , pp. 546-553
    • Kim, J.H.1    Kang, M.J.2    Park, C.U.3
  • 32
    • 0030982897 scopus 로고    scopus 로고
    • Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA
    • 2-s2.0-0030982897
    • Costello J. F., Plass C., Arap W., Chapman V. M., Held W. A., Berger M. S., Su Huang H.-J., Cavenee W. K., Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Research 1997 57 7 1250 1254 2-s2.0-0030982897
    • (1997) Cancer Research , vol.57 , Issue.7 , pp. 1250-1254
    • Costello, J.F.1    Plass, C.2    Arap, W.3    Chapman, V.M.4    Held, W.A.5    Berger, M.S.6    Su Huang, H.-J.7    Cavenee, W.K.8
  • 34
    • 0028024945 scopus 로고
    • Somatic mutations of the MTS (Multiple Tumor Suppressor) 1/CDK4I (Cyclin-Dependent Kinase-4 Inhibitor) gene in human primary non-small cell lung carcinomas
    • 2-s2.0-0028024945 10.1006/bbrc.1994.2090
    • Hayashi N., Sugimoto Y., Tsuchiya E., Ogawa M., Nakamura Y., Somatic mutations of the MTS (Multiple Tumor Suppressor) 1/CDK4I (Cyclin-Dependent Kinase-4 Inhibitor) gene in human primary non-small cell lung carcinomas. Biochemical and Biophysical Research Communications 1994 202 3 1426 1430 2-s2.0-0028024945 10.1006/bbrc.1994.2090
    • (1994) Biochemical and Biophysical Research Communications , vol.202 , Issue.3 , pp. 1426-1430
    • Hayashi, N.1    Sugimoto, Y.2    Tsuchiya, E.3    Ogawa, M.4    Nakamura, Y.5
  • 36
    • 0031860559 scopus 로고    scopus 로고
    • Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells
    • 2-s2.0-0031860559
    • Drexler H. G., Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 1998 12 6 845 859 2-s2.0-0031860559
    • (1998) Leukemia , vol.12 , Issue.6 , pp. 845-859
    • Drexler, H.G.1
  • 37
    • 0030332113 scopus 로고    scopus 로고
    • The molecular biology of esophageal carcinoma
    • 2-s2.0-0030332113
    • Meltzer S. J., The molecular biology of esophageal carcinoma. Recent Results in Cancer Research 1996 142 1 8 2-s2.0-0030332113
    • (1996) Recent Results in Cancer Research , vol.142 , pp. 1-8
    • Meltzer, S.J.1
  • 38
    • 0030114446 scopus 로고    scopus 로고
    • Analysis of the p16INK4, p15INK4B genes abnormality and the amplification of cyclin D1 gene in esophageal cancer
    • 2-s2.0-0030114446
    • Takamura H., Fushida S., Hashimoto T., Yagi M., Miyazaki I., Analysis of the p16INK4, p15INK4B genes abnormality and the amplification of cyclin D1 gene in esophageal cancer. Nippon Rinsho 1996 54 4 1043 1048 2-s2.0-0030114446
    • (1996) Nippon Rinsho , vol.54 , Issue.4 , pp. 1043-1048
    • Takamura, H.1    Fushida, S.2    Hashimoto, T.3    Yagi, M.4    Miyazaki, I.5
  • 39
    • 0028991396 scopus 로고
    • Mutation of cell cycle regulators: Biological and clinical implications for human neoplasia
    • 2-s2.0-0028991396
    • Cordon-Cardo C., Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. American Journal of Pathology 1995 147 3 545 560 2-s2.0-0028991396
    • (1995) American Journal of Pathology , vol.147 , Issue.3 , pp. 545-560
    • Cordon-Cardo, C.1
  • 40
    • 0031048236 scopus 로고    scopus 로고
    • Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
    • 2-s2.0-0031048236 10.1038/nm0297-231
    • Loda M., Cukor B., Tam S. W., Lavin P., Fiorentino M., Draetta G. F., Milburn Jessup J., Pagano M., Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Medicine 1997 3 2 231 234 2-s2.0-0031048236 10.1038/nm0297-231
    • (1997) Nature Medicine , vol.3 , Issue.2 , pp. 231-234
    • Loda, M.1    Cukor, B.2    Tam, S.W.3    Lavin, P.4    Fiorentino, M.5    Draetta, G.F.6    Milburn Jessup, J.7    Pagano, M.8
  • 41
    • 0030889473 scopus 로고    scopus 로고
    • Expression of cyclin D1 correlates with malignancy in human ovarian tumours
    • 2-s2.0-0030889473
    • Barbieri F., Cagnoli M., Ragni N., Pedullà F., Foglia G., Alama A., Expression of cyclin D1 correlates with malignancy in human ovarian tumours. British Journal of Cancer 1997 75 9 1263 1268 2-s2.0-0030889473
    • (1997) British Journal of Cancer , vol.75 , Issue.9 , pp. 1263-1268
    • Barbieri, F.1    Cagnoli, M.2    Ragni, N.3    Pedullà, F.4    Foglia, G.5    Alama, A.6
  • 42
    • 0031028265 scopus 로고    scopus 로고
    • Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (min) mice and human familial adenomatous polyposis patients
    • 2-s2.0-0031028265
    • Zhang T., Nanney L. B., Luongo C., Lamps L., Heppner K. J., Dubois R. N., Beauchamp R. D., Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (min) mice and human familial adenomatous polyposis patients. Cancer Research 1997 57 1 169 175 2-s2.0-0031028265
    • (1997) Cancer Research , vol.57 , Issue.1 , pp. 169-175
    • Zhang, T.1    Nanney, L.B.2    Luongo, C.3    Lamps, L.4    Heppner, K.J.5    Dubois, R.N.6    Beauchamp, R.D.7
  • 43
    • 0028829571 scopus 로고
    • Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage
    • 2-s2.0-0028829571
    • Nakagawa K., Conrad N. K., Williams J. P., Johnson B. E., Kelley M. J., Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage. Oncogene 1995 11 9 1843 1851 2-s2.0-0028829571
    • (1995) Oncogene , vol.11 , Issue.9 , pp. 1843-1851
    • Nakagawa, K.1    Conrad, N.K.2    Williams, J.P.3    Johnson, B.E.4    Kelley, M.J.5
  • 44
    • 0030467624 scopus 로고    scopus 로고
    • The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis
    • 2-s2.0-0030467624
    • Bartkova J., Lukas J., Guldberg P., Alsner J., Kirkin A. F., Zeuthen J., Bartek J., The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Research 1996 56 23 5475 5483 2-s2.0-0030467624
    • (1996) Cancer Research , vol.56 , Issue.23 , pp. 5475-5483
    • Bartkova, J.1    Lukas, J.2    Guldberg, P.3    Alsner, J.4    Kirkin, A.F.5    Zeuthen, J.6    Bartek, J.7
  • 45
    • 84875265267 scopus 로고    scopus 로고
    • Comparison of gene expression profiling in sarcomas and mesenchymal stem cells identifies tumorigenic pathways in chemically induced rat sarcoma model
    • 909453 10.5402/2012/909453
    • Honoki K., Fujii H., Tohma Y., Comparison of gene expression profiling in sarcomas and mesenchymal stem cells identifies tumorigenic pathways in chemically induced rat sarcoma model. Oncology 2012 2012 8 909453 10.5402/2012/909453
    • (2012) Oncology , vol.2012 , pp. 8
    • Honoki, K.1    Fujii, H.2    Tohma, Y.3
  • 47
    • 37549057005 scopus 로고    scopus 로고
    • The anaplastic lymphoma kinase in the pathogenesis of cancer
    • 2-s2.0-37549057005 10.1038/nrc2291
    • Chiarle R., Voena C., Ambrogio C., Piva R., Inghirami G., The anaplastic lymphoma kinase in the pathogenesis of cancer. Nature Reviews Cancer 2008 8 1 11 23 2-s2.0-37549057005 10.1038/nrc2291
    • (2008) Nature Reviews Cancer , vol.8 , Issue.1 , pp. 11-23
    • Chiarle, R.1    Voena, C.2    Ambrogio, C.3    Piva, R.4    Inghirami, G.5
  • 48
    • 0032484533 scopus 로고    scopus 로고
    • Analysis of cyclin e and CDK2 in ovarian cancer: Gene amplification and RNA overexpression
    • Marone M., Scambia G., Giannitelli C., Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression. International Journal of Cancer 1998 75 1 34 39
    • (1998) International Journal of Cancer , vol.75 , Issue.1 , pp. 34-39
    • Marone, M.1    Scambia, G.2    Giannitelli, C.3
  • 49
    • 0032525883 scopus 로고    scopus 로고
    • Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma
    • 2-s2.0-0032525883
    • Easton J., Wei T., Lahti J. M., Kidd V. J., Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma. Cancer Research 1998 58 12 2624 2632 2-s2.0-0032525883
    • (1998) Cancer Research , vol.58 , Issue.12 , pp. 2624-2632
    • Easton, J.1    Wei, T.2    Lahti, J.M.3    Kidd, V.J.4
  • 50
    • 0029664339 scopus 로고    scopus 로고
    • Germline mutations in the p16(INK4a) binding domain of CDK4 in familial melanoma
    • 2-s2.0-0029664339 10.1038/ng0196-97
    • Zuo L., Weger J., Yang Q., Goldstein A. M., Tucker M. A., Walker G. J., Hayward N., Dracopoli N. C., Germline mutations in the p16(INK4a) binding domain of CDK4 in familial melanoma. Nature Genetics 1996 12 1 97 99 2-s2.0-0029664339 10.1038/ng0196-97
    • (1996) Nature Genetics , vol.12 , Issue.1 , pp. 97-99
    • Zuo, L.1    Weger, J.2    Yang, Q.3    Goldstein, A.M.4    Tucker, M.A.5    Walker, G.J.6    Hayward, N.7    Dracopoli, N.C.8
  • 51
    • 0036163745 scopus 로고    scopus 로고
    • Regulation of cyclin-Cdk activity in mammalian cells
    • 2-s2.0-0036163745 10.1007/s00018-002-8410-1
    • Obaya A. J., Sedivy J. M., Regulation of cyclin-Cdk activity in mammalian cells. Cellular and Molecular Life Sciences 2002 59 1 126 142 2-s2.0-0036163745 10.1007/s00018-002-8410-1
    • (2002) Cellular and Molecular Life Sciences , vol.59 , Issue.1 , pp. 126-142
    • Obaya, A.J.1    Sedivy, J.M.2
  • 52
    • 41849142290 scopus 로고    scopus 로고
    • Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma
    • 2-s2.0-41849142290 10.3748/wjg.14.1734
    • Matsuda Y., Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma. World Journal of Gastroenterology 2008 14 11 1734 1740 2-s2.0-41849142290 10.3748/wjg.14.1734
    • (2008) World Journal of Gastroenterology , vol.14 , Issue.11 , pp. 1734-1740
    • Matsuda, Y.1
  • 53
    • 0033548548 scopus 로고    scopus 로고
    • Pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways: A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells
    • 2-s2.0-0033548548 10.1074/jbc.274.11.7341
    • Lee R. J., Albanese C., Stenger R. J., Watanabe G., Inghirami G., Haines G. K. III, Webster M., Muller W. J., Brugge J. S., Davis R. J., Pestell R. G., pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways: a role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. The Journal of Biological Chemistry 1999 274 11 7341 7350 2-s2.0-0033548548 10.1074/jbc.274.11.7341
    • (1999) The Journal of Biological Chemistry , vol.274 , Issue.11 , pp. 7341-7350
    • Lee, R.J.1    Albanese, C.2    Stenger, R.J.3    Watanabe, G.4    Inghirami, G.5    Haines III, G.K.6    Webster, M.7    Muller, W.J.8    Brugge, J.S.9    Davis, R.J.10    Pestell, R.G.11
  • 54
    • 0028970609 scopus 로고
    • Transforming p21(ras) mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions
    • 2-s2.0-0028970609 10.1074/jbc.270.40.23589
    • Albanese C., Johnson J., Watanabe G., Eklund N., Vu D., Arnold A., Pestell R. G., Transforming p21(ras) mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. The Journal of Biological Chemistry 1995 270 40 23589 23597 2-s2.0-0028970609 10.1074/jbc.270.40.23589
    • (1995) The Journal of Biological Chemistry , vol.270 , Issue.40 , pp. 23589-23597
    • Albanese, C.1    Johnson, J.2    Watanabe, G.3    Eklund, N.4    Vu, D.5    Arnold, A.6    Pestell, R.G.7
  • 55
    • 0028049592 scopus 로고
    • Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice
    • 2-s2.0-0028049592
    • Lovec H., Grzeschiczek A., Kowalski M., Möröy T., Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. The EMBO Journal 1994 13 15 3487 3495 2-s2.0-0028049592
    • (1994) The EMBO Journal , vol.13 , Issue.15 , pp. 3487-3495
    • Lovec, H.1    Grzeschiczek, A.2    Kowalski, M.3    Möröy, T.4
  • 56
    • 0027943249 scopus 로고
    • Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle
    • 2-s2.0-0027943249
    • Daksis J. I., Lu R. Y., Facchini L. M., Marhin W. W., Penn L. J. Z., Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene 1994 9 12 3635 3645 2-s2.0-0027943249
    • (1994) Oncogene , vol.9 , Issue.12 , pp. 3635-3645
    • Daksis, J.I.1    Lu, R.Y.2    Facchini, L.M.3    Marhin, W.W.4    Penn, L.J.Z.5
  • 58
    • 77953610741 scopus 로고    scopus 로고
    • A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3′ enhancers does not promote by itself B-cell malignancies
    • 2-s2.0-77953610741 10.1016/j.leukres.2009.11.017
    • Fiancette R., Amin R., Truffinet V., Vincent-Fabert C., Cogné N., Cogné M., Denizot Y., A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3′ enhancers does not promote by itself B-cell malignancies. Leukemia Research 2010 34 8 1043 1051 2-s2.0-77953610741 10.1016/j.leukres.2009.11.017
    • (2010) Leukemia Research , vol.34 , Issue.8 , pp. 1043-1051
    • Fiancette, R.1    Amin, R.2    Truffinet, V.3    Vincent-Fabert, C.4    Cogné, N.5    Cogné, M.6    Denizot, Y.7
  • 59
    • 0028243879 scopus 로고
    • Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
    • 2-s2.0-0028243879 10.1038/369669a0
    • Wang T. C., Cardiff R. D., Zukerberg L., Lees E., Arnold A., Schmidt E. V., Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994 369 6482 669 671 2-s2.0-0028243879 10.1038/369669a0
    • (1994) Nature , vol.369 , Issue.6482 , pp. 669-671
    • Wang, T.C.1    Cardiff, R.D.2    Zukerberg, L.3    Lees, E.4    Arnold, A.5    Schmidt, E.V.6
  • 60
    • 23044508946 scopus 로고    scopus 로고
    • Cyclin D1 in breast cancer pathogenesis
    • 2-s2.0-23044508946 10.1200/JCO.2005.05.064
    • Arnold A., Papanikolaou A., Cyclin D1 in breast cancer pathogenesis. Journal of Clinical Oncology 2005 23 18 4215 4224 2-s2.0-23044508946 10.1200/JCO.2005.05.064
    • (2005) Journal of Clinical Oncology , vol.23 , Issue.18 , pp. 4215-4224
    • Arnold, A.1    Papanikolaou, A.2
  • 61
    • 0028274940 scopus 로고
    • Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene
    • 2-s2.0-0028274940
    • Bodrug S. E., Warner B. J., Bath M. L., Lindeman G. J., Harris A. W., Adams J. M., Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. The EMBO Journal 1994 13 9 2124 2130 2-s2.0-0028274940
    • (1994) The EMBO Journal , vol.13 , Issue.9 , pp. 2124-2130
    • Bodrug, S.E.1    Warner, B.J.2    Bath, M.L.3    Lindeman, G.J.4    Harris, A.W.5    Adams, J.M.6
  • 63
    • 0029161567 scopus 로고
    • Deregulation of cyclin e in breast cancer
    • 2-s2.0-0029161567
    • Keyomarsi K., Conte D., Toyofuku W., Fox M. P., Deregulation of cyclin E in breast cancer. Oncogene 1995 11 5 941 953 2-s2.0-0029161567
    • (1995) Oncogene , vol.11 , Issue.5 , pp. 941-953
    • Keyomarsi, K.1    Conte, D.2    Toyofuku, W.3    Fox, M.P.4
  • 64
    • 0038679686 scopus 로고    scopus 로고
    • Cyclin e overexpression and amplification in human tumours
    • Schraml P., Bucher C., Bissig H., Cyclin E overexpression and amplification in human tumours. The Journal of Pathology 2003 200 3 375 382
    • (2003) The Journal of Pathology , vol.200 , Issue.3 , pp. 375-382
    • Schraml, P.1    Bucher, C.2    Bissig, H.3
  • 65
    • 0030736080 scopus 로고    scopus 로고
    • Overexpression of cyclin e in acute myelogenous leukemia
    • 2-s2.0-0030736080
    • Lida H., Towatari M., Tanimoto M., Morishita Y., Kodera Y., Saito H., Overexpression of cyclin E in acute myelogenous leukemia. Blood 1997 90 9 3707 3721 2-s2.0-0030736080
    • (1997) Blood , vol.90 , Issue.9 , pp. 3707-3721
    • Lida, H.1    Towatari, M.2    Tanimoto, M.3    Morishita, Y.4    Kodera, Y.5    Saito, H.6
  • 66
    • 0028953560 scopus 로고
    • Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck
    • 2-s2.0-0028953560
    • Michalides R., van Veelen N., Hart A., Loftus B., Wientjens E., Balm A., Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Research 1995 55 5 975 978 2-s2.0-0028953560
    • (1995) Cancer Research , vol.55 , Issue.5 , pp. 975-978
    • Michalides, R.1    Van Veelen, N.2    Hart, A.3    Loftus, B.4    Wientjens, E.5    Balm, A.6
  • 68
    • 0030969478 scopus 로고    scopus 로고
    • Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis
    • 2-s2.0-0030969478
    • Gansauge S., Gansauge F., Ramadani M., Stobbe H., Rau B., Harada N., Beger H. G., Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Research 1997 57 9 1634 1637 2-s2.0-0030969478
    • (1997) Cancer Research , vol.57 , Issue.9 , pp. 1634-1637
    • Gansauge, S.1    Gansauge, F.2    Ramadani, M.3    Stobbe, H.4    Rau, B.5    Harada, N.6    Beger, H.G.7
  • 69
    • 0034162037 scopus 로고    scopus 로고
    • Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma
    • 2-s2.0-0034162037 10.1016/S1368-8375(99)00078-0
    • Mineta H., Miura K., Takebayashi S., Ueda Y., Misawa K., Harada H., Wennerberg J., Dictor M., Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma. Oral Oncology 2000 36 2 194 198 2-s2.0-0034162037 10.1016/S1368-8375(99)00078-0
    • (2000) Oral Oncology , vol.36 , Issue.2 , pp. 194-198
    • Mineta, H.1    Miura, K.2    Takebayashi, S.3    Ueda, Y.4    Misawa, K.5    Harada, H.6    Wennerberg, J.7    Dictor, M.8
  • 70
    • 0031447727 scopus 로고    scopus 로고
    • Expression of cyclins D1 and e in human colon adenocarcinomas
    • 2-s2.0-0031447727
    • Sutter T., Doi S., Carnevale K. A., Arber N., Weinstein I. B., Expression of cyclins D1 and E in human colon adenocarcinomas. Journal of Medicine 1997 28 5-6 285 309 2-s2.0-0031447727
    • (1997) Journal of Medicine , vol.28 , Issue.5-6 , pp. 285-309
    • Sutter, T.1    Doi, S.2    Carnevale, K.A.3    Arber, N.4    Weinstein, I.B.5
  • 71
    • 33646262907 scopus 로고    scopus 로고
    • Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome
    • 2-s2.0-33646262907 10.1158/1078-0432.CCR-05-2135
    • Tzankov A., Gschwendtner A., Augustin F., Fiegl M., Obermann E. C., Dirnhofer S., Went P., Diffuse large B-cell lymphoma with overexpression of cyclin E substantiates poor standard treatment response and inferior outcome. Clinical Cancer Research 2006 12 7 I 2125 2132 2-s2.0-33646262907 10.1158/1078-0432.CCR-05-2135
    • (2006) Clinical Cancer Research , vol.12 , Issue.7 , pp. 2125-2132
    • Tzankov, A.1    Gschwendtner, A.2    Augustin, F.3    Fiegl, M.4    Obermann, E.C.5    Dirnhofer, S.6    Went, P.7
  • 72
    • 33748855444 scopus 로고    scopus 로고
    • Cyclin e expression and prognosis in breast cancer patients: A meta-analysis of published studies
    • 2-s2.0-33748855444 10.1080/07357900600894799
    • Wang L., Shao Z., Cyclin E expression and prognosis in breast cancer patients: a meta-analysis of published studies. Cancer Investigation 2006 24 6 581 587 2-s2.0-33748855444 10.1080/07357900600894799
    • (2006) Cancer Investigation , vol.24 , Issue.6 , pp. 581-587
    • Wang, L.1    Shao, Z.2
  • 73
    • 80955144114 scopus 로고    scopus 로고
    • Overexpression of cyclin e isoforms correlates with poor prognosis in rectal cancer
    • 2-s2.0-80955144114
    • Zhou Y. J., Xie Y. T., Gu J., Yan L., Guan G. X., Liu X., Overexpression of cyclin e isoforms correlates with poor prognosis in rectal cancer. European Journal of Surgical Oncology 2011 77 12 1078 1084 2-s2.0-80955144114
    • (2011) European Journal of Surgical Oncology , vol.77 , Issue.12 , pp. 1078-1084
    • Zhou, Y.J.1    Xie, Y.T.2    Gu, J.3    Yan, L.4    Guan, G.X.5    Liu, X.6
  • 74
    • 0031028246 scopus 로고    scopus 로고
    • Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin e
    • 2-s2.0-0031028246
    • Bortner D. M., Rosenberg M. P., Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Molecular and Cellular Biology 1997 17 1 453 459 2-s2.0-0031028246
    • (1997) Molecular and Cellular Biology , vol.17 , Issue.1 , pp. 453-459
    • Bortner, D.M.1    Rosenberg, M.P.2
  • 75
    • 0031048716 scopus 로고    scopus 로고
    • Expression of cell-cycle regulators p27(Kip1) and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
    • 2-s2.0-0031048716 10.1038/nm0297-222
    • Porter P. L., Malone K. E., Heagerty P. J., Alexander G. M., Gatti L. A., Firpo E. J., Daling J. R., Roberts J. M., Expression of cell-cycle regulators p27(Kip1) and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Medicine 1997 3 2 222 225 2-s2.0-0031048716 10.1038/nm0297-222
    • (1997) Nature Medicine , vol.3 , Issue.2 , pp. 222-225
    • Porter, P.L.1    Malone, K.E.2    Heagerty, P.J.3    Alexander, G.M.4    Gatti, L.A.5    Firpo, E.J.6    Daling, J.R.7    Roberts, J.M.8
  • 77
    • 0034914215 scopus 로고    scopus 로고
    • Cyclin e overexpression as an independent risk factor of visceral relapse in breast cancer
    • 2-s2.0-0034914215 10.1053/ejso.2001.1137
    • Kim H. K., Park I., Heo D. S., Noh D., Choe K., Bang Y., Kim N. K., Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer. European Journal of Surgical Oncology 2001 27 5 464 471 2-s2.0-0034914215 10.1053/ejso.2001.1137
    • (2001) European Journal of Surgical Oncology , vol.27 , Issue.5 , pp. 464-471
    • Kim, H.K.1    Park, I.2    Heo, D.S.3    Noh, D.4    Choe, K.5    Bang, Y.6    Kim, N.K.7
  • 78
    • 0032980308 scopus 로고    scopus 로고
    • The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer
    • 2-s2.0-0032980308 10.1146/annurev.med.50.1.401
    • Tsihlias J., Kapusta L., Slingerland J., The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annual Review of Medicine 1999 50 401 423 2-s2.0-0032980308 10.1146/annurev.med.50.1.401
    • (1999) Annual Review of Medicine , vol.50 , pp. 401-423
    • Tsihlias, J.1    Kapusta, L.2    Slingerland, J.3
  • 79
    • 0034103810 scopus 로고    scopus 로고
    • Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma
    • 2-s2.0-0034103810
    • Straume O., Sviland L., Akslen L. A., Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma. Clinical Cancer Research 2000 6 5 1845 1853 2-s2.0-0034103810
    • (2000) Clinical Cancer Research , vol.6 , Issue.5 , pp. 1845-1853
    • Straume, O.1    Sviland, L.2    Akslen, L.A.3
  • 80
    • 0035407504 scopus 로고    scopus 로고
    • Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer
    • 2-s2.0-0035407504
    • Zhang H., Sun X. F., Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer. International Journal of Oncology 2001 19 1 49 52 2-s2.0-0035407504
    • (2001) International Journal of Oncology , vol.19 , Issue.1 , pp. 49-52
    • Zhang, H.1    Sun, X.F.2
  • 81
    • 0346689073 scopus 로고    scopus 로고
    • Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer
    • 2-s2.0-0346689073 10.1159/000074651
    • Juuti A., Nordling S., Louhimo J., Lundin J., Von Boguslawski K., Haglund C., Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer. Oncology 2003 65 4 371 377 2-s2.0-0346689073 10.1159/000074651
    • (2003) Oncology , vol.65 , Issue.4 , pp. 371-377
    • Juuti, A.1    Nordling, S.2    Louhimo, J.3    Lundin, J.4    Von Boguslawski, K.5    Haglund, C.6
  • 82
    • 0033986568 scopus 로고    scopus 로고
    • Prognostic significance of p27(kip1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas
    • 2-s2.0-0033986568
    • Tenjo T., Toyoda M., Okuda J., Watanabe I., Yamamoto T., Tanaka K., Ohtani M., Nohara T., Kawasaki H., Tanigawa N., Prognostic significance of p27(kip1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas. Oncology 2000 58 1 45 51 2-s2.0-0033986568
    • (2000) Oncology , vol.58 , Issue.1 , pp. 45-51
    • Tenjo, T.1    Toyoda, M.2    Okuda, J.3    Watanabe, I.4    Yamamoto, T.5    Tanaka, K.6    Ohtani, M.7    Nohara, T.8    Kawasaki, H.9    Tanigawa, N.10
  • 83
    • 0036743489 scopus 로고    scopus 로고
    • Co-deletion of both p15/p16 genes correlates with poor prognosis non-small cell lung cnacer
    • 2-s2.0-0036743489
    • Hu Y., Liao M., Ding J., Zhou J., Xu K., Co-deletion of both p15/p16 genes correlates with poor prognosis non-small cell lung cnacer. Chinese Journal of Cancer Research 2002 14 3 216 219 2-s2.0-0036743489
    • (2002) Chinese Journal of Cancer Research , vol.14 , Issue.3 , pp. 216-219
    • Hu, Y.1    Liao, M.2    Ding, J.3    Zhou, J.4    Xu, K.5
  • 84
    • 0042334830 scopus 로고    scopus 로고
    • Loss of p16 contributes to p27 sequestration by cyclin D l-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma
    • 2-s2.0-0042334830
    • Matsuda Y., Ichida T., Genda T., Yamagiwa S., Aoyagi Y., Asakura H., Loss of p16 contributes to p27 sequestration by cyclin D l-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma. Clinical Cancer Research 2003 9 9 3389 3396 2-s2.0-0042334830
    • (2003) Clinical Cancer Research , vol.9 , Issue.9 , pp. 3389-3396
    • Matsuda, Y.1    Ichida, T.2    Genda, T.3    Yamagiwa, S.4    Aoyagi, Y.5    Asakura, H.6
  • 85
    • 39049090370 scopus 로고    scopus 로고
    • Hypermethylation of p16 gene promoter correlates with loss of p16 expression that results in poorer prognosis in esophageal squamous cell carcinomas
    • 2-s2.0-39049090370 10.1111/j.1442-2050.2007.00735.x
    • Fujiwara S., Noguchi T., Takeno S., Kimura Y., Fumoto S., Kawahara K., Hypermethylation of p16 gene promoter correlates with loss of p16 expression that results in poorer prognosis in esophageal squamous cell carcinomas. Diseases of the Esophagus 2008 21 2 125 131 2-s2.0-39049090370 10.1111/j.1442-2050.2007.00735.x
    • (2008) Diseases of the Esophagus , vol.21 , Issue.2 , pp. 125-131
    • Fujiwara, S.1    Noguchi, T.2    Takeno, S.3    Kimura, Y.4    Fumoto, S.5    Kawahara, K.6
  • 86
    • 0030941813 scopus 로고    scopus 로고
    • Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome
    • 2-s2.0-0030941813
    • Kees U. R., Burton P. R., Lü C., Baker D. L., Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome. Blood 1997 89 11 4161 4166 2-s2.0-0030941813
    • (1997) Blood , vol.89 , Issue.11 , pp. 4161-4166
    • Kees, U.R.1    Burton, P.R.2    Lü, C.3    Baker, D.L.4
  • 88
    • 0035134705 scopus 로고    scopus 로고
    • Methylation of the p15INK4B gene in myelodysplastic syndrome: It can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation
    • 2-s2.0-0035134705 10.1046/j.1365-2141.2001.02496.x
    • Tien H., Tang J., Tsay W., Liu M., Lee F., Wang C., Chen Y., Shen M., Methylation of the p15INK4B gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation. British Journal of Haematology 2001 112 1 148 154 2-s2.0-0035134705 10.1046/j.1365-2141.2001.02496.x
    • (2001) British Journal of Haematology , vol.112 , Issue.1 , pp. 148-154
    • Tien, H.1    Tang, J.2    Tsay, W.3    Liu, M.4    Lee, F.5    Wang, C.6    Chen, Y.7    Shen, M.8
  • 89
    • 0032980308 scopus 로고    scopus 로고
    • The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer
    • 2-s2.0-0032980308 10.1146/annurev.med.50.1.401
    • Tsihlias J., Kapusta L., Slingerland J., The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annual Review of Medicine 1999 50 401 423 2-s2.0-0032980308 10.1146/annurev.med.50.1.401
    • (1999) Annual Review of Medicine , vol.50 , pp. 401-423
    • Tsihlias, J.1    Kapusta, L.2    Slingerland, J.3
  • 90
    • 78751505998 scopus 로고    scopus 로고
    • P27: A barometer of signaling deregulation and potential predictor of response to targeted therapies
    • 2-s2.0-78751505998 10.1158/1078-0432.CCR-10-0752
    • Wander S. A., Zhao D., Slingerland J. M., p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies. Clinical Cancer Research 2011 17 1 12 18 2-s2.0-78751505998 10.1158/1078-0432.CCR-10- 0752
    • (2011) Clinical Cancer Research , vol.17 , Issue.1 , pp. 12-18
    • Wander, S.A.1    Zhao, D.2    Slingerland, J.M.3
  • 91
    • 0033874069 scopus 로고    scopus 로고
    • Cyclin D2 overexpression and lack of p27 correlate positively and cyclin e inversely with a poor prognosis in gastric cancer cases
    • 2-s2.0-0033874069
    • Takano Y., Kato Y., van Diest P. J., Masuda M., Mitomi H., Okayasu I., Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. American Journal of Pathology 2000 156 2 585 594 2-s2.0-0033874069
    • (2000) American Journal of Pathology , vol.156 , Issue.2 , pp. 585-594
    • Takano, Y.1    Kato, Y.2    Van Diest, P.J.3    Masuda, M.4    Mitomi, H.5    Okayasu, I.6
  • 92
    • 34447312829 scopus 로고    scopus 로고
    • Loss of p27(Kip1) CDKI is a predictor of poor recurrence-free and cancer-specific survival in patients with renal cancer
    • 2-s2.0-34447312829 10.1007/s11255-006-9077-6
    • Pertia A., Nikoleishvili D., Trsintsadze O., Gogokhia N., Managadze L., Chkhotua A., Loss of p27(Kip1) CDKI is a predictor of poor recurrence-free and cancer-specific survival in patients with renal cancer. International Urology and Nephrology 2007 39 2 381 387 2-s2.0-34447312829 10.1007/s11255-006-9077-6
    • (2007) International Urology and Nephrology , vol.39 , Issue.2 , pp. 381-387
    • Pertia, A.1    Nikoleishvili, D.2    Trsintsadze, O.3    Gogokhia, N.4    Managadze, L.5    Chkhotua, A.6
  • 93
    • 67649424560 scopus 로고    scopus 로고
    • P21 in cancer: Intricate networks and multiple activities
    • 2-s2.0-67649424560
    • Abbas T., Dutta A., P21 in cancer: intricate networks and multiple activities. Nature Reviews Cancer 2009 9 6 400 414 2-s2.0-67649424560
    • (2009) Nature Reviews Cancer , vol.9 , Issue.6 , pp. 400-414
    • Abbas, T.1    Dutta, A.2
  • 94
    • 84879516965 scopus 로고    scopus 로고
    • MicroRNA miR-24 promotes cell proliferation by targeting the CDKs inhibitors p27Kip1 and p16INK4a
    • Giglio S., Cirombella R., Amodeo R., MicroRNA miR-24 promotes cell proliferation by targeting the CDKs inhibitors p27Kip1 and p16INK4a. Journal of Cellular Physiology 2013 228 10 2015 2023
    • (2013) Journal of Cellular Physiology , vol.228 , Issue.10 , pp. 2015-2023
    • Giglio, S.1    Cirombella, R.2    Amodeo, R.3
  • 97
    • 77951092028 scopus 로고    scopus 로고
    • Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region
    • 2-s2.0-77951092028 10.1038/onc.2010.34
    • Wu S., Huang S., Ding J., Zhao Y., Liang L., Liu T., Zhan R., He X., Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region. Oncogene 2010 29 15 2302 2308 2-s2.0-77951092028 10.1038/onc.2010.34
    • (2010) Oncogene , vol.29 , Issue.15 , pp. 2302-2308
    • Wu, S.1    Huang, S.2    Ding, J.3    Zhao, Y.4    Liang, L.5    Liu, T.6    Zhan, R.7    He, X.8
  • 98
    • 16244410580 scopus 로고    scopus 로고
    • Combined antitumor activity of 7-hydroxystaurosporine (UCN-01) and tamoxifen against human breast carcinoma in vitro and in vivo
    • 2-s2.0-16244410580 10.1007/BF02966727
    • Koh J., Kubota T., Koyama T., Migita T., Hashimoto M., Hosoda Y., Kitajima M., Combined antitumor activity of 7-hydroxystaurosporine (UCN-01) and tamoxifen against human breast carcinoma in vitro and in vivo. Breast Cancer 2002 10 3 260 267 2-s2.0-16244410580 10.1007/BF02966727
    • (2002) Breast Cancer , vol.10 , Issue.3 , pp. 260-267
    • Koh, J.1    Kubota, T.2    Koyama, T.3    Migita, T.4    Hashimoto, M.5    Hosoda, Y.6    Kitajima, M.7
  • 99
    • 0038798471 scopus 로고    scopus 로고
    • Prominent induction of cyclin B1 in G2/M renal cancer cells with butyrolactone 1
    • 2-s2.0-0038798471 10.1046/j.1442-2042.2003.00626.x
    • Kasuya Y., Hosaka Y., Matsushima H., Goto T., Kitamura T., Okuyama A., Prominent induction of cyclin B1 in G2/M renal cancer cells with butyrolactone 1. International Journal of Urology 2003 10 6 323 331 2-s2.0-0038798471 10.1046/j.1442-2042.2003.00626.x
    • (2003) International Journal of Urology , vol.10 , Issue.6 , pp. 323-331
    • Kasuya, Y.1    Hosaka, Y.2    Matsushima, H.3    Goto, T.4    Kitamura, T.5    Okuyama, A.6
  • 100
    • 84872876588 scopus 로고    scopus 로고
    • Indirubin-3′-oxime induces mitochondrial dysfunction and triggers growth inhibition and cell cycle arrest in human neuroblastoma cells
    • Liao X. M., Leung K. N., Indirubin-3′-oxime induces mitochondrial dysfunction and triggers growth inhibition and cell cycle arrest in human neuroblastoma cells. Oncology Reports 2013 29 1 371 379
    • (2013) Oncology Reports , vol.29 , Issue.1 , pp. 371-379
    • Liao, X.M.1    Leung, K.N.2
  • 101
    • 68149161142 scopus 로고    scopus 로고
    • Anti-tumor activity of noble indirubin derivatives in human solid tumor models in vitro
    • 2-s2.0-68149161142 10.1007/s12272-009-1614-2
    • Kim S., Choi S. J., Kim Y., Kuh H., Anti-tumor activity of noble indirubin derivatives in human solid tumor models in vitro. Archives of Pharmacal Research 2009 32 6 915 922 2-s2.0-68149161142 10.1007/s12272-009-1614- 2
    • (2009) Archives of Pharmacal Research , vol.32 , Issue.6 , pp. 915-922
    • Kim, S.1    Choi, S.J.2    Kim, Y.3    Kuh, H.4
  • 102
    • 67650073265 scopus 로고    scopus 로고
    • Cell cycle kinases as therapeutic targets for cancer
    • 2-s2.0-67650073265 10.1038/nrd2907
    • Lapenna S., Giordano A., Cell cycle kinases as therapeutic targets for cancer. Nature Reviews Drug Discovery 2009 8 7 547 566 2-s2.0-67650073265 10.1038/nrd2907
    • (2009) Nature Reviews Drug Discovery , vol.8 , Issue.7 , pp. 547-566
    • Lapenna, S.1    Giordano, A.2
  • 103
    • 84887026442 scopus 로고    scopus 로고
    • Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance
    • 10.1038/bjc.2013.584
    • Kaliszczak M., Patel H., Kroll S. H., Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance. British Journal of Cancer 2013 109 9 2356 2367 10.1038/bjc.2013.584
    • (2013) British Journal of Cancer , vol.109 , Issue.9 , pp. 2356-2367
    • Kaliszczak, M.1    Patel, H.2    Kroll, S.H.3
  • 104
    • 84887617944 scopus 로고    scopus 로고
    • Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo
    • 10.1038/pcan.2013.38
    • Chiu S. C., Huang S. Y., Chen S. P., Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo. Prostate Cancer and Prostatic Diseases 2013 16 4 315 322 10.1038/pcan.2013.38
    • (2013) Prostate Cancer and Prostatic Diseases , vol.16 , Issue.4 , pp. 315-322
    • Chiu, S.C.1    Huang, S.Y.2    Chen, S.P.3
  • 105
    • 84883428665 scopus 로고    scopus 로고
    • Euphol arrests breast cancer cells at the G1 phase through the modulation of cyclin D1, p21 and p27 expression
    • Wang L., Wang G., Yang D., Euphol arrests breast cancer cells at the G1 phase through the modulation of cyclin D1, p21 and p27 expression. Molecular Medicine Reports 2013 8 4 1279 1285
    • (2013) Molecular Medicine Reports , vol.8 , Issue.4 , pp. 1279-1285
    • Wang, L.1    Wang, G.2    Yang, D.3
  • 106
    • 84885613823 scopus 로고    scopus 로고
    • Novel inhibitors of cyclin-dependent kinases combat hepatocellular carcinoma without inducing chemoresistance
    • 10.1158/1535-7163.MCT-13-0263
    • Haider C., Grubinger M., Reznícková E., Novel inhibitors of cyclin-dependent kinases combat hepatocellular carcinoma without inducing chemoresistance. Molecular Cancer Therapeutics 2013 12 10 1947 1957 10.1158/1535-7163.MCT-13-0263
    • (2013) Molecular Cancer Therapeutics , vol.12 , Issue.10 , pp. 1947-1957
    • Haider, C.1    Grubinger, M.2    Reznícková, E.3
  • 107
    • 84886769857 scopus 로고    scopus 로고
    • Identification of small molecule inhibitors of p27Kip1 ubiquitination by high-throughput screening
    • 10.1111/cas.12246
    • Ooi L. C., Watanabe N., Futamura Y., Identification of small molecule inhibitors of p27Kip1 ubiquitination by high-throughput screening. Cancer Science 2013 10.1111/cas.12246
    • (2013) Cancer Science
    • Ooi, L.C.1    Watanabe, N.2    Futamura, Y.3
  • 108
    • 84881412642 scopus 로고    scopus 로고
    • A novel series of highly potent 2, 6, 9-trisubstituted purine cyclin-dependent kinase inhibitors
    • Gurcký T., Jorda R., Zatloukal M., A novel series of highly potent 2, 6, 9-trisubstituted purine cyclin-dependent kinase inhibitors. Journal of Medicinal Chemistry 2013 56 15 6234 6247
    • (2013) Journal of Medicinal Chemistry , vol.56 , Issue.15 , pp. 6234-6247
    • Gurcký, T.1    Jorda, R.2    Zatloukal, M.3
  • 109
    • 84879934068 scopus 로고    scopus 로고
    • Recombinant human decorin upregulates p57KIP2 expression in HepG2 hepatoma cell lines
    • Hamid A. S., Li J., Wang Y., Recombinant human decorin upregulates p57KIP2 expression in HepG2 hepatoma cell lines. Molecular Medicine Reports 2013 8 2 511 516
    • (2013) Molecular Medicine Reports , vol.8 , Issue.2 , pp. 511-516
    • Hamid, A.S.1    Li, J.2    Wang, Y.3
  • 110
    • 84878252263 scopus 로고    scopus 로고
    • Cyclin-dependent kinase inhibitor therapy for hematologic malignancies
    • Bose P., Simmons G. L., Grant S., Cyclin-dependent kinase inhibitor therapy for hematologic malignancies. Expert Opinion on Investigational Drugs 2013 22 6 723 738
    • (2013) Expert Opinion on Investigational Drugs , vol.22 , Issue.6 , pp. 723-738
    • Bose, P.1    Simmons, G.L.2    Grant, S.3
  • 111
    • 77954757207 scopus 로고    scopus 로고
    • Therapeutic CDK4/6 inhibition in breast cancer: Key mechanisms of response and failure
    • 2-s2.0-77954757207 10.1038/onc.2010.154
    • Dean J. L., Thangavel C., McClendon A. K., Reed C. A., Knudsen E. S., Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure. Oncogene 2010 29 28 4018 4032 2-s2.0-77954757207 10.1038/onc.2010.154
    • (2010) Oncogene , vol.29 , Issue.28 , pp. 4018-4032
    • Dean, J.L.1    Thangavel, C.2    McClendon, A.K.3    Reed, C.A.4    Knudsen, E.S.5
  • 112
    • 84871198345 scopus 로고    scopus 로고
    • Inhibition of proliferation and induction of G1-phase cell-cycle arrest by dFMGEN, a novel genistein derivative, in lung carcinoma A549 cells
    • Peng B., Cao J., Yi S., Inhibition of proliferation and induction of G1-phase cell-cycle arrest by dFMGEN, a novel genistein derivative, in lung carcinoma A549 cells. Drug and Chemical Toxicology 2013 26 2 196 294
    • (2013) Drug and Chemical Toxicology , vol.26 , Issue.2 , pp. 196-294
    • Peng, B.1    Cao, J.2    Yi, S.3
  • 113
    • 84881032733 scopus 로고    scopus 로고
    • Flavopiridol synergizes with sorafenib to induce cytotoxicity and potentiate antitumorigenic activity in EGFR/HER-2 and mutant RAS/RAF breast cancer model systems
    • Nagaria T. S., Williams J. L., Leduc C., Flavopiridol synergizes with sorafenib to induce cytotoxicity and potentiate antitumorigenic activity in EGFR/HER-2 and mutant RAS/RAF breast cancer model systems. Neoplasia 2013 15 8 939 951
    • (2013) Neoplasia , vol.15 , Issue.8 , pp. 939-951
    • Nagaria, T.S.1    Williams, J.L.2    Leduc, C.3
  • 115
    • 43749113595 scopus 로고    scopus 로고
    • Modulation of miRNA activity in human cancer: A new paradigm for cancer gene therapy?
    • 2-s2.0-43749113595 10.1038/cgt.2008.8
    • Tong A. W., Nemunaitis J., Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Therapy 2008 15 6 341 355 2-s2.0-43749113595 10.1038/cgt.2008.8
    • (2008) Cancer Gene Therapy , vol.15 , Issue.6 , pp. 341-355
    • Tong, A.W.1    Nemunaitis, J.2
  • 116
    • 84867322248 scopus 로고    scopus 로고
    • MicroRNA and cutaneous melanoma: From discovery to prognosis and therapy
    • Segura M. F., Greenwald H. S., Hanniford D., MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy. Carcinogenesis 2012 33 10 1823 1832
    • (2012) Carcinogenesis , vol.33 , Issue.10 , pp. 1823-1832
    • Segura, M.F.1    Greenwald, H.S.2    Hanniford, D.3
  • 117
    • 39049174710 scopus 로고    scopus 로고
    • Antipyretic analgesics: Nonsteroidal antiinflammatory drugs, selective COX-2 inhibitors, paracetamol and pyrazolinones
    • 2-s2.0-39049174710
    • Hinz B., Brune K., Antipyretic analgesics: nonsteroidal antiinflammatory drugs, selective COX-2 inhibitors, paracetamol and pyrazolinones. Handbook of Experimental Pharmacology 2007 177 65 93 2-s2.0-39049174710
    • (2007) Handbook of Experimental Pharmacology , vol.177 , pp. 65-93
    • Hinz, B.1    Brune, K.2
  • 118
    • 0033563675 scopus 로고    scopus 로고
    • Nonsteroidal anti-inflammatory drugs attenuate epidermal growth factor- induced proliferation independent of prostaglandin synthesis inhibition
    • 2-s2.0-0033563675 10.1006/jsre.1999.5640
    • Kokoska E. R., Smith G. S., Wolff A. B., Deshpande Y., Miller T. A., Nonsteroidal anti-inflammatory drugs attenuate epidermal growth factor- induced proliferation independent of prostaglandin synthesis inhibition. Journal of Surgical Research 1999 84 2 186 192 2-s2.0-0033563675 10.1006/jsre.1999.5640
    • (1999) Journal of Surgical Research , vol.84 , Issue.2 , pp. 186-192
    • Kokoska, E.R.1    Smith, G.S.2    Wolff, A.B.3    Deshpande, Y.4    Miller, T.A.5
  • 119
    • 0029896486 scopus 로고    scopus 로고
    • NSAID-induced polyp regression in familial adenomatous polyposis patients
    • 2-s2.0-0029896486
    • Giardiello F. M., NSAID-induced polyp regression in familial adenomatous polyposis patients. Gastroenterology Clinics of North America 1996 25 2 349 362 2-s2.0-0029896486
    • (1996) Gastroenterology Clinics of North America , vol.25 , Issue.2 , pp. 349-362
    • Giardiello, F.M.1
  • 120
    • 0031985225 scopus 로고    scopus 로고
    • Non-steroidol anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis
    • 2-s2.0-0031985225
    • Barnes C. J., Cameron I. L., Hardman W. E., Lee M., Non-steroidol anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis. British Journal of Cancer 1998 77 4 573 580 2-s2.0-0031985225
    • (1998) British Journal of Cancer , vol.77 , Issue.4 , pp. 573-580
    • Barnes, C.J.1    Cameron, I.L.2    Hardman, W.E.3    Lee, M.4
  • 122
    • 33845344739 scopus 로고    scopus 로고
    • Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic
    • 2-s2.0-33845344739 10.1016/j.critrevonc.2006.07.001
    • de Groot D. J. A., de Vries E. G. E., Groen H. J. M., de Jong S., Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic. Critical Reviews in Oncology/Hematology 2007 61 1 52 69 2-s2.0-33845344739 10.1016/j.critrevonc.2006.07.001
    • (2007) Critical Reviews in Oncology/Hematology , vol.61 , Issue.1 , pp. 52-69
    • De Groot, D.J.A.1    De Vries, E.G.E.2    Groen, H.J.M.3    De Jong, S.4
  • 123
    • 33745073168 scopus 로고    scopus 로고
    • Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-ibuprofen treatment
    • 2-s2.0-33745073168 10.1016/j.ejphar.2006.04.030
    • Janssen A., Maier T. J., Schiffmann S., Coste O., Seegel M., Geisslinger G., Grösch S., Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-ibuprofen treatment. European Journal of Pharmacology 2006 540 1-3 24 33 2-s2.0-33745073168 10.1016/j.ejphar.2006.04.030
    • (2006) European Journal of Pharmacology , vol.540 , Issue.1-3 , pp. 24-33
    • Janssen, A.1    Maier, T.J.2    Schiffmann, S.3    Coste, O.4    Seegel, M.5    Geisslinger, G.6    Grösch, S.7
  • 124
    • 57349145254 scopus 로고    scopus 로고
    • Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling
    • 2-s2.0-57349145254 10.1016/j.canlet.2008.08.006
    • Zhou H., Huang L., Sun Y., Rigas B., Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling. Cancer Letters 2009 273 2 292 299 2-s2.0-57349145254 10.1016/j.canlet.2008.08.006
    • (2009) Cancer Letters , vol.273 , Issue.2 , pp. 292-299
    • Zhou, H.1    Huang, L.2    Sun, Y.3    Rigas, B.4
  • 125
    • 1642407595 scopus 로고    scopus 로고
    • Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells
    • 2-s2.0-1642407595 10.1016/j.bcp.2003.12.014
    • Maier T. J., Schilling K., Schmidt R., Geisslinger G., Grösch S., Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. Biochemical Pharmacology 2004 67 8 1469 1478 2-s2.0-1642407595 10.1016/j.bcp.2003.12.014
    • (2004) Biochemical Pharmacology , vol.67 , Issue.8 , pp. 1469-1478
    • Maier, T.J.1    Schilling, K.2    Schmidt, R.3    Geisslinger, G.4    Grösch, S.5
  • 126
    • 0041833663 scopus 로고    scopus 로고
    • Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: Effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s)
    • 2-s2.0-0041833663
    • Narayanan B. A., Condon M. S., Bosland M. C., Narayanan N. K., Reddy B. S., Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s). Clinical Cancer Research 2003 9 9 3503 3513 2-s2.0-0041833663
    • (2003) Clinical Cancer Research , vol.9 , Issue.9 , pp. 3503-3513
    • Narayanan, B.A.1    Condon, M.S.2    Bosland, M.C.3    Narayanan, N.K.4    Reddy, B.S.5
  • 127
    • 0036892307 scopus 로고    scopus 로고
    • Mechanisms underlying nonsteroidal anti-inflammatory drug-induced p27Kip1 expression
    • 2-s2.0-0036892307 10.1124/mol.62.6.1515
    • Huang Y., Chuang L., Hung W., Mechanisms underlying nonsteroidal anti-inflammatory drug-induced p27Kip1 expression. Molecular Pharmacology 2002 62 6 1515 1521 2-s2.0-0036892307 10.1124/mol.62.6.1515
    • (2002) Molecular Pharmacology , vol.62 , Issue.6 , pp. 1515-1521
    • Huang, Y.1    Chuang, L.2    Hung, W.3
  • 128
    • 0029115954 scopus 로고
    • Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells
    • 2-s2.0-0029115954
    • Shiff S. J., Qiao L., Tsai L.-L., Rigas B., Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. Journal of Clinical Investigation 1995 96 1 491 503 2-s2.0-0029115954
    • (1995) Journal of Clinical Investigation , vol.96 , Issue.1 , pp. 491-503
    • Shiff, S.J.1    Qiao, L.2    Tsai, L.-L.3    Rigas, B.4
  • 130
    • 11244334168 scopus 로고    scopus 로고
    • Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF- B activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation
    • 2-s2.0-11244334168 10.1038/sj.onc.1208169
    • Takada Y., Bhardwaj A., Potdar P., Aggarwal B. B., Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF- B activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene 2004 23 57 9247 9258 2-s2.0-11244334168 10.1038/sj.onc.1208169
    • (2004) Oncogene , vol.23 , Issue.57 , pp. 9247-9258
    • Takada, Y.1    Bhardwaj, A.2    Potdar, P.3    Aggarwal, B.B.4
  • 131
    • 0035180624 scopus 로고    scopus 로고
    • Non-steroidal anti-inflammatory drugs inhibit telomerase activity in head and neck squamous carcinoma cell lines
    • 2-s2.0-0035180624 10.1002/hed.1150
    • Thurnher D., Bakroeva M., Formanek M., Knerer B., Kornfehl J., Non-steroidal anti-inflammatory drugs inhibit telomerase activity in head and neck squamous carcinoma cell lines. Head and Neck 2001 23 12 1049 1055 2-s2.0-0035180624 10.1002/hed.1150
    • (2001) Head and Neck , vol.23 , Issue.12 , pp. 1049-1055
    • Thurnher, D.1    Bakroeva, M.2    Formanek, M.3    Knerer, B.4    Kornfehl, J.5
  • 133
    • 58149486385 scopus 로고    scopus 로고
    • NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells
    • 2-s2.0-58149486385 10.1158/1535-7163.MCT-08-0928
    • Aryankalayil M. J., Palayoor S. T., Cerna D., Falduto M. T., Magnuson S. R., Coleman C. N., NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells. Molecular Cancer Therapeutics 2009 8 1 261 273 2-s2.0-58149486385 10.1158/1535-7163.MCT-08-0928
    • (2009) Molecular Cancer Therapeutics , vol.8 , Issue.1 , pp. 261-273
    • Aryankalayil, M.J.1    Palayoor, S.T.2    Cerna, D.3    Falduto, M.T.4    Magnuson, S.R.5    Coleman, C.N.6
  • 134
    • 67649973868 scopus 로고    scopus 로고
    • Ibuprofen and hydrogel-released ibuprofen in the reduction of inflammation-induced migration in melanoma cells
    • 2-s2.0-67649973868 10.1111/j.1365-2133.2009.09220.x
    • Redpath M., Marques C. M. G., Dibden C., Waddon A., Lalla R., MacNeil S., Ibuprofen and hydrogel-released ibuprofen in the reduction of inflammation-induced migration in melanoma cells. British Journal of Dermatology 2009 161 1 25 33 2-s2.0-67649973868 10.1111/j.1365-2133.2009.09220.x
    • (2009) British Journal of Dermatology , vol.161 , Issue.1 , pp. 25-33
    • Redpath, M.1    Marques, C.M.G.2    Dibden, C.3    Waddon, A.4    Lalla, R.5    Macneil, S.6
  • 135
    • 37049039276 scopus 로고    scopus 로고
    • The p38 MAPK pathway mediates aryl propionic acid-induced messenger RNA stability of p75NTR in prostate cancer cells
    • 2-s2.0-37049039276 10.1158/0008-5472.CAN-07-1792
    • Quann E. J., Khwaja F., Djakiew D., The p38 MAPK pathway mediates aryl propionic acid-induced messenger RNA stability of p75NTR in prostate cancer cells. Cancer Research 2007 67 23 11402 11410 2-s2.0-37049039276 10.1158/0008-5472.CAN-07-1792
    • (2007) Cancer Research , vol.67 , Issue.23 , pp. 11402-11410
    • Quann, E.J.1    Khwaja, F.2    Djakiew, D.3
  • 136
    • 0036387468 scopus 로고    scopus 로고
    • Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells
    • 2-s2.0-0036387468 10.1007/s00280-002-0485-8
    • Andrews J., Djakiew D., Krygier S., Andrews P., Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells. Cancer Chemotherapy and Pharmacology 2002 50 4 277 284 2-s2.0-0036387468 10.1007/s00280-002-0485-8
    • (2002) Cancer Chemotherapy and Pharmacology , vol.50 , Issue.4 , pp. 277-284
    • Andrews, J.1    Djakiew, D.2    Krygier, S.3    Andrews, P.4
  • 137
    • 0034816925 scopus 로고    scopus 로고
    • Cyclooxygenase-independent actions of cyclooxygenase inhibitors
    • 2-s2.0-0034816925 10.1096/fj.01-0390rev
    • Tegeder I., Pfeilschifter J., Geisslinger G., Cyclooxygenase-independent actions of cyclooxygenase inhibitors. The FASEB Journal 2001 15 12 2057 2072 2-s2.0-0034816925 10.1096/fj.01-0390rev
    • (2001) The FASEB Journal , vol.15 , Issue.12 , pp. 2057-2072
    • Tegeder, I.1    Pfeilschifter, J.2    Geisslinger, G.3
  • 139
    • 0033711708 scopus 로고    scopus 로고
    • Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle
    • 2-s2.0-0033711708 10.1016/S0955-0674(00)00151-4
    • Ekholm S. V., Reed S. I., Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle. Current Opinion in Cell Biology 2000 12 6 676 684 2-s2.0-0033711708 10.1016/S0955-0674(00)00151-4
    • (2000) Current Opinion in Cell Biology , vol.12 , Issue.6 , pp. 676-684
    • Ekholm, S.V.1    Reed, S.I.2
  • 140
    • 0035041740 scopus 로고    scopus 로고
    • Molecular mechanisms controlling the cell cycle: Main considerations and implications in oncology
    • 2-s2.0-0035041740 10.1016/S1278-3218(01)00087-7
    • Viallard J. F., Lacombe F., Belloc F., Pellegrin J. L., Reiffers J., Molecular mechanisms controlling the cell cycle: main considerations and implications in oncology. Cancer/Radiotherapie 2001 5 2 109 129 2-s2.0-0035041740 10.1016/S1278-3218(01)00087-7
    • (2001) Cancer/Radiotherapie , vol.5 , Issue.2 , pp. 109-129
    • Viallard, J.F.1    Lacombe, F.2    Belloc, F.3    Pellegrin, J.L.4    Reiffers, J.5
  • 142
    • 0028849274 scopus 로고
    • P21 Is necessary for the p53-mediated G1 arrest in human cancer cells
    • 2-s2.0-0028849274
    • Waldman T., Kinzler K. W., Vogelstein B., p21 Is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Research 1995 55 22 5187 5190 2-s2.0-0028849274
    • (1995) Cancer Research , vol.55 , Issue.22 , pp. 5187-5190
    • Waldman, T.1    Kinzler, K.W.2    Vogelstein, B.3
  • 143
    • 0141707813 scopus 로고    scopus 로고
    • Emerging roles for E2F: Beyond the G1/S transition and DNA replication
    • 2-s2.0-0141707813 10.1016/S1535-6108(03)00080-1
    • Cam H., Dynlacht B. D., Emerging roles for E2F: beyond the G1/S transition and DNA replication. Cancer Cell 2003 3 4 311 316 2-s2.0-0141707813 10.1016/S1535-6108(03)00080-1
    • (2003) Cancer Cell , vol.3 , Issue.4 , pp. 311-316
    • Cam, H.1    Dynlacht, B.D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.